Skip to content
S6866Senate2023-2024 SessionSame asA3981

Require Breast Surgery Options Info

Official title

“Relates to hospital care for mastectomy, lumpectomy, and lymph node dissection patients”

Sponsor Julia SalazarSD-18+1 co-sponsorAffects Health
Status
In Senate Committee
Women's Issues
Impact
5/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Women's Issues

What's happening

This bill requires hospitals to inform mastectomy, lumpectomy, and lymph node dissection patients about reconstructive and flat closure options before surgery.

Why it matters

  1. Ensures patients are informed about all surgical options, including “going flat” (aesthetic flat closure),. which addresses the needs of those who do not want breast reconstruction and may otherwise be unaware this is a supported choice.

  2. Mandates written, pre-surgical disclosure about insurance coverage for reconstructive and flat closure procedures,. helping patients understand their financial rights and reducing unexpected costs or insurance denials.

  3. Requires hospitals to explain how patients can access reconstructive or flat closure care—including the right to transfer to another facility or delay reconstruction,. empowering patients who may not have immediate access to specialized surgical teams.

  4. Aims to standardize the quality and completeness of information given to breast cancer surgery patients,. potentially reducing confusion, disparities in care, and the likelihood of regret or dissatisfaction with surgical outcomes.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Mastectomy, lumpectomy and lymph node dissection patients

    They would receive written information explicitly describing going breastless or flat and having an aesthetic flat closure before consenting to surgery.

  • General hospitals performing these procedures

    They would need to ensure their required patient information includes going breastless or flat alongside aesthetic flat closure.

  • Surgeons and patient education staff

    The bill would expand the options that hospital materials must describe, including their advantages and disadvantages, before patients consent to surgery.

Headline styles

Require Breast Surgery Options Info

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Julia Salazar

Senator · Senate District 18

Chair, Crime Victims, Crime And Correction

1 Co-sponsor

History

  1. Referred to women's issues
  2. Referred to women's issues

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A3981Assembly

Inform Breast Surgery Patients

In Senate Committee · Women's Issues · Sponsor Chantel Jackson

Impact 5 · Moderate0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

6866

2023-2024 Regular Sessions

IN SENATE

May 11, 2023

Introduced by Sens. SALAZAR, CLEARE -- read twice and ordered printed, and when printed to be committed to the Committee on Women's Issues

AN ACT to amend the public health law, in relation to hospital care for mastectomy, lumpectomy, and lymph node dissection patients

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 2 of section 2803-o of the public health law, as amended by chapter 571 of the laws of 2022, is amended to read as follows:

2. Every general hospital that provides mastectomy surgery, lymph node dissection or a lumpectomy shall provide information to the patient concerning the option of reconstructive surgery following such procedures, including both breast and chest wall reconstructive surgery and the availability of coverage for reconstructive surgery, in accordance with the provisions of sections three thousand two hundred sixteen, three thousand two hundred twenty-one and four thousand three hundred three of the insurance law and applicable provisions of federal law. The information shall be provided to the patient in writing and in advance of obtaining consent to the surgical procedure. The information provided shall include at least the following:

(a) a description of the various reconstructive options and the advantages and disadvantages of each. Such description shall include going breastless or flat and having an aesthetic flat closure as such term is defined by the National Cancer Institute;

(b) a description of the provisions assuring coverage by public and private insurance plans of the costs related to reconstructive surgery under federal and state law;

(c) a description of how a patient may access reconstructive care, including the potential of transferring care to a facility that provides reconstructive care or choosing to pursue reconstruction after

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD07183-01-3

completion of breast cancer surgery and chemo/radiotherapy, if warranted;

(d) such other information as may be required by the commissioner.

§ 2. This act shall take effect on the first of January next succeeding the date on which it shall have become a law.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to hospital care for mastectomy, lumpectomy, and lymph node dissection patients

Purpose or general idea of bill

This bill requires that every general hospital that provides mastectomy surgery, lymph node dissection or a lumpectomy shall provide information to the patient concerning their options following such procedures.

Summary of provisions

Section 1. Subdivision 2 of section 2803-o of the public health law, as amended by chapter 571 of the laws of 2022, is amended to include the option of an aesthetic flat closure or going flat, which is recon- struction of the chest wall contour with no excess tissue after a mastectomy.

Read the full memo (883 words)

Justification

The Centers for Disease Control indicates that breast cancer is the second most common cancer among women in the United States. Women should be armed with all the information they need to make the best decision for themselves and their bodies, this very personal decision should include the option of going breastless or going flat and obtaining an aesthetically pleasing outcome; an aesthetic flat closure.

A 2021 study released by the journal Annals of Surgical Oncology (1) indicates that more women are choosing to go flat and opt out of breast reconstruction after mastectomy surgery. The study further indicates that for many of those women their decision was not supported by their surgeon siting older studies indicating reconstruction provided a better quality of life option for women. In recent years, however, a growing number of women and advocacy groups have been outspoken about going breastless or "going flat" and the pushback received from breast surgeons who have pushed heavily towards reconstruction.

Women undergoing cancer treatment are dealing with enough trauma and having to also worry about their surgeon going against their treatment choice should not be part of their of their recovery journey. In many cases, surgeons who do a mastectomy with no reconstruction often leave extra skin in case the patient changes her mind and then decides to choose implants. However, this action adds stress and the need to obtain "revision surgery" to remove the excess skin; sometimes more than one revision surgery may be needed.

A woman's choice to go flat is very personal and can include wanting to avoid additional surgeries, feel comfortable with the idea of going flat, and even looking to avoid additional complications. In October 2021, the FDA strengthened the safety requirements for manufacturers requiring that patients are warned of possible complications from the use of breast implant.(2) This action by the FDA was a direct result of issues faced by thousands of women after receiving breast implants. Implants have been linked to a long list of side effects and exposure to cancer causing materials. The FDA's new requirement ensures patients are informed of all risks associated with using breast implants. The patient should be fully informed of all risks to allow them to make the best choice for themselves. Another issue faced by women who choose going flat is a surgeon's failure to provide an aesthetically pleasing outcome after surgery. This leads to more surgeries, which can be costly for patients who may have high copayments or may not be able to take time off from work. According to the recently recognized term by the National Cancer Institute, an "aesthetic flat closure is a type of surgery that is done to rebuild the shape of the chest wall after one or both breasts are removed. An aesthetic flat closure may also be done after removal of a breast implant that was used to restore breast shape. During an aesthetic flat closure, extra skin, fat, and other tissue in the breast area is removed. The remaining tissue is then tightened and smoothed out so that the chest wall appears flat."

Federal protections are already in place to ensure women undergoing breast cancer receive the care they need. The 1998 Women's Health and Cancer Rights Act is the federal law that provides protections to those who choose to have breast reconstruction in connection with a mastectomy(3). Coverage must be provided for: 1) all stages of recon- struction of the breast on which the mastectomy has been performed; 2)surgery and reconstruction of the other breast to produce a symmet- rical appearance; and 3) prosthesis and treatment of physical compli- cations of all stages of the mastectomy, including lymphedema.

This bill ensures breast cancer patients are informed of their choices, which include the option to go flat. As more women continue to opt to go flat, their decision should be respected by the medical professionals providing care during their breast cancer journey.

Prior legislative history

This is a new bill.

Fiscal implications

None.

Effective date

Effective immediately. (1) Baker, J.L., Dizon, D.S., Wenziger, C.M. et al. "Going Flat" After Mastectomy: Patient-Reported Outcomes by Online Survey. Ann Surg Oncol 28, 2493-2505 2021). HTTPS://DOI.ORG/10.1245/ S10434-020-09448-9 (2) October 27, 2021: FDA News Release: FDA Strengthens Safety Require- ments and Updates Study Results for Breast Implants. Agency adds restrictions and approves new labeling for all approved breast implants HTTPS://WWW.FDA.GOV/NEW-EVENTS/PRESS-ANNOUNCEMENTS/FDA- STRENGTHENS-SAF- ETY-REQUIREMENTS-AND-UPDATES- STUDYRESULTS-BREAST-IMPLANTS (3) The U.S. Women's Health and Cancer Rights Act, also known as Janet's Law, signed into law on October 21, 1998 as part of the 1999 OMNIBUS BILL (PUB.L. 105-277 https://www.govinfo. gov/content/pkg/PLAW-105pub1277/html/PLAW-105pub1277.htm

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.